Genz_ad.qxp 4/2/08 03:18 Page 15
Start now and shape the future
Start with Renagel and you’re planning
for your patients’ future. Renagel
1
controls serum phosphorus within
2
the KDOQI target range without any
3
risk of calcium or metal accumulation.
Sevelamer is a KDOQI-recommended
2
first-line treatment option. Renagel
is the only phosphate binder proven to
2,3
reduce LDL-cholesterol by up to 31%.
1 S P E V D U 4 V N N B S Z 3 F O B H F M
¡
N H à M N D P B U F E U " D U J B W C F M T F V C T U B O D F U T T F W F M B N F S G S P N U I F T F T U V E J F T Q B U J F O U T
B O E G S P N V O D P O U S P M M F E D M J O J D B M U S J B M T Q B U J F O U T
B S F
4 V C K F D U U P N F E J D B M Q S F T D S J Q U J P O $ P N Q P T J U J P O & B D I U B C M F U D P O U B J O T N H T M J T U F F E W F C M Z B G S N F R V F O D Z F S I F S F O F Y U ( B T U S P J O U F T U J O B M E J T P S E F S T O B V T F B
W U J O H
P N J B C E P N J O B M
& B D I U B C M F U B M T P D P O U B J O T T J M J D B
D P M M P J E B M B O I F I Z U B E C M F U S P D V P B T U J O H B O Q B J O E T
U D F P O T U J Q B B S J D U J P O B
D E J B J E S S I P F B
5 E Z T Q F Q T J B W F S Z D P N N P O
B O E á B U V M F O D F P N N P O D
/ F S W P V T
D P O U B J O T I Z Q S P N F M M P T F B O E E J B D F U Z M B U F E N P O P H M Z D F S J E F T 5 I F Q S J O U J O H L D J O P O U B J O T J T Z T U F N S P E J T P S E F S O T I F B E B D I F W F S Z D P N N P O
7 B T D V M B S E J T P S E F S T I Z Q P U F O T J P O
I Z Q F S U F O T J P O
P Y J E F C M B D L &
Q S P Q Z M F O F H M Z D P M B O E I Z Q 5 I S P F S N B Q F F V U J D M M P T J F O E J D B U J P O T 3 F O B H F M
¡
W F S Z D P N N P O
( F O F S T P S E F B M E S J T B O E B E N J O J T U S B U J P O T J U F D P O E J U J P O T J O Q B W F S Z D P N N P O
J T J O E J D B U F E G P S U I F D P O U S P M P G I Z Q F S Q I P T Q I B U B F N J B J O J W J O H B E V I M U Q B F N P E J B M Z B U J F O T J T U T S 4 L F D J O F B O E T V C D V U B O F P V T E J T P S E F S T Q S V S J U J T W F S Z D P N N P O
B O E S B T I D P N N P O
* O G F D U J P O T
P S Q F S J U P O F B M E J B M Z T J T 3 F O B H
¡
F M T I P V M E C F V T F E X J U I J O U I F D P O U F Y U P G B N V M U J Q M F U I F S B Q F V U J D B O E J O G F T U B U J P O T Q I B S Z O H J U J T D P N N P O
5 I F S F Q P S U J O H S B U F J T D M B T T J G J F E B T W F S Z D P N N P O
B Q Q S P B D I
X I J D I D P V M E J O D M V E F D B M D J V N T V Q Q M F N F O U T
E J I Z E S P Y Z N J O 7 J U B % P S P O F \
D P N N P O \
V O D P N N P O \
S
B S F
\
P G J U T B O B M P H V F T U P D P O U S P M U I F E F W F M P Q N F O U P G S F O B M C P O F E J T F B T F $ P O U S B J O E J D B U J P O T W F S Z S B S F
J O D M V E J O H J T B U F P M E . P T U P G U I F T F F W F O U O M Z T B P C S T F S F D W F E P N N P
) Z Q P Q I P T Q I B U B F N J B P S C P X F M P C T U S V D J P O U ) Z Q F S T F O T J U J W J U Z U P T F W F M B N F S P S U P B O Z P G U I F J O Q B U J F O U T X J U I 4 U B H F $ I S P O J D , J E O F % J T Z F B T F B O E B S F O P U O F D F T T B S J M Z B U S J C V U U B C M F U P
F Y D J Q J F O U T J O U I F Q S P E V D U 1 P T T J C M F T J E F F G G F D U T * O Q B S B M M F M E F T J H O T U V E J F T J O W P M W J O H 3 F O B H F M
¡
1 P T U N B S L F U J O H F Y Q F S J F O D F * O W F S Z S B S F D B T F T
J O U F T U J O B M P C T U S V D U J P O B O E J M F V T
I B F N P E J B M Z T J T Q B U J F O U T X J U I U S F B U N F O U E V S B U J P O P G X F F F B M L T B E J B M Z O T J T E T V C J M F V T Q F S I B J W U F P C F F O O P C T F S W F E J O Q B F O U T U J E V S J O H U S F B U N F O U X J U I 3 F O B H
¡
F M 1 S P E V D U - J D F O D F
Q B U J F O U T X J U I U S F B U N F O U E V S B U J P O G P X F F L T
U I F N P T U G S F R V F O U M Z P D D V S O H S J \ P G I P M E F S ( F O [ Z N F & V S P Q F # 7
( P P J N F F S
% % / B B S E F O
5 I F / F U I F S M B O E % B T U F P G
Q B U J F O U T
V O E F T J S B C M F F G G F D U T Q P T T J C M Z P S Q S P C B C M Z S F M B
¡
U X F S F E U F B M M P 3 J O U I F O S F B W J T J P O H F M P G U F Y U T U + V O F
H B T U S P J O U F T U J O B M E J T P S E F S T T Z T U F N P S H B O D M B T T % B U B Q P T T J C M Z P S Q S P C B C M Z S F M B U F P 3 E U F B H O F M
¡
" U U F O U J P O 1 M F B T F T F F G V M M Q S F T D S J C J O H J O G P S N B U J P O
References:
1. Chertow GM et al. Kidney Int 2002;62:245-252.
2. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Bone Metabolism and
Disease in Chronic Kidney Disease. AmJKidneyDis2003;42(Suppl 3):S1-S201.
3. Renagel Summary of Product Characteristics.
© 2007, Genzyme Corporation. All rights reserved. RP142/6 07/07
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76